Bruker Corporation (BRKRP) vs Kymera Therapeutics, Inc. (KYMR)
A side-by-side comparison of Bruker Corporation and Kymera Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BRKRP
Bruker Corporation
$445.04HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
KYMR
Kymera Therapeutics, Inc.
$105.98HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BRKRP vs KYMR
growth of $100 · dividends reinvested · last 1yBRKRP +94.8% (+94.8%/yr)KYMR +160.3% (+160.3%/yr)KYMR compounded faster over this window
BRKRP KYMR
BRKRP vs KYMR: by the numbers
- •BRKRP is the larger company ($8.93B vs $8.72B market cap).
- •Both run net losses; BRKRP's is the smaller (-2.03% vs -285.41% net margin).
- •KYMR grew revenue faster over the past five years (10.22% vs 9.10% CAGR).
- •BRKRP pays a dividend (3.35% yield), while KYMR has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BRKRP | KYMR |
|---|---|---|
| Forward P/E | 209.72 | N/A |
| P/S ratio | 2.55 | 83.03 |
| P/B ratio | 3.72 | 5.78 |
| EV / EBITDA | 29.89 | N/A |
| FCF yield | 1.05% | N/A |
Profitability
| Metric | BRKRP | KYMR |
|---|---|---|
| Gross margin | 46.69% | 101.98% |
| Operating margin | 3.61% | -891.33% |
| Net margin | -2.03% | -285.41% |
| ROE | -2.97% | -19.85% |
| ROIC | 2.56% | -22.30% |
Dividends
| Metric | BRKRP | KYMR |
|---|---|---|
| Dividend yield | 3.35% | N/A |
Growth (annualized)
| Metric | BRKRP | KYMR |
|---|---|---|
| Revenue CAGR (5Y) | 9.10% | 10.22% |
| FCF CAGR (5Y) | -21.33% | N/A |
| Total return CAGR (5Y) | N/A | 12.31% |
Frequently asked
- Which has grown faster, BRKRP or KYMR?
- Over the past five years, KYMR grew revenue faster — BRKRP at a 9.10% CAGR versus KYMR at 10.22%.
- Does BRKRP or KYMR pay a bigger dividend?
- BRKRP pays a dividend (3.35% yield), while KYMR has no payments in the available dividend history.
Go deeper
Dig into the metrics
Bruker dividend yieldBruker ROEKymera Therapeutics ROEBruker operating marginKymera Therapeutics operating marginBruker revenue growthKymera Therapeutics revenue growthBruker free cash flowKymera Therapeutics free cash flow
Bruker & Kymera Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.